COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021

BACKGROUND: Multiple sclerosis (MS) organizations have recommended that adults with MS obtain the COVID-19 vaccination. Vaccine hesitancy is a barrier to full COVID-19 inoculation in the general population. Whether vaccine hesitancy is also a barrier towards optimizing vaccination rates in the MS co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehde, Dawn M., Roberts, Michelle K., Humbert, Andrew T., Herring, Tracy E., Alschuler, Kevin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295053/
https://www.ncbi.nlm.nih.gov/pubmed/34325399
http://dx.doi.org/10.1016/j.msard.2021.103163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295053/
https://www.ncbi.nlm.nih.gov/pubmed/34325399
http://dx.doi.org/10.1016/j.msard.2021.103163

Ejemplares similares